Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,089 | 6,398 | 6,953 | 10,352 | 12,653 |
| Receivables | 920 | 530 | 1,380 | N/A | N/A |
| TOTAL | $5,736 | $7,646 | $9,149 | $10,735 | $13,329 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 184 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 75 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $259 |
| Total Assets | $5,736 | $7,646 | $9,149 | $10,735 | $13,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,102 | 1,909 | 2,141 | 2,325 | 852 |
| TOTAL | $2,376 | $2,271 | $2,495 | $2,672 | $1,192 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 94 | 185 | 607 |
| TOTAL | $N/A | $N/A | $94 | $185 | $607 |
| Total Liabilities | $2,376 | $2,271 | $2,589 | $2,857 | $1,799 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,135 | 832 | 755 | 755 | 755 |
| Common Shares | N/A | N/A | 2 | 2 | N/A |
| Retained earnings | -242,527 | -240,473 | -239,244 | -237,873 | -233,939 |
| TOTAL | $3,360 | $5,375 | $6,560 | $7,878 | $11,789 |
| Total Liabilities And Equity | $5,736 | $7,646 | $9,149 | $10,735 | $13,588 |